Bullish Outlook Therapeutics, Inc. (NASDAQ:OTLK) insiders filled their treasuries with US$557k worth of stock over last year
yahoo.com
news
2022-05-27 11:25:05

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Outlook Therapeutics, Inc. (NASDAQ:OTLK), that sends out a positive message to the company's shareholders.

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

Check out our latest analysis for Outlook Therapeutics

Outlook Therapeutics Insider Transactions Over The Last Year

In the last twelve months, the biggest single purchase by an insider was when Independent Director Kurt Hilzinger bought US$257k worth of shares at a price of US$1.
